MYB and neoplasm: Previous studies have demonstrated the important tumour-suppressive role of miR-193b-3p, as it targets several members of the RAS-RAF-MEK-ERK pathway which is crucial for cell cycle and proliferation, as well as c-KIT [41,42] and the MYB oncogene [43].